Journey Medical Corp (DERM) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $7.36 (+0.00%), Market cap $0.17B, 52-week low–high $4.39 ~ $9.26.
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammat
Financial statements, price targets, institutional (13F) holdings and related news for Journey Medical Corp are updated in real time on BlackAll Trade.
Journey Medical Corp trades at $7.36 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Journey Medical Corp has a market cap of about $0.17B.
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions i